Medical YOga dUring CANcer Treatment in a Digital or Physical Setting - a PREFERensbased Study
YouCanPrefer
Medical Yoga During Cancer Treatment in a Digital or Physical Setting - a Preference-based Study
1 other identifier
interventional
163
1 country
1
Brief Summary
To enhance the implementation of yoga in cancer care, studies that explore patients with cancer preferences for the execution of yoga, effects, and the experience of participating in group yoga sessions online compared to in-person sessions is required. The aim of the YouCanPrefer-study is to explore preferences, expectations, implementation, experiences, and effects of participating in in-person group yoga sessions at a yoga studio compared to participating in online-yoga at home for patients with cancer undergoing oncological treatment. Additionally, the aim is to study health-related outcomes of yoga. Patients diagnosed with cancer undergoing oncological treatment at two hospitals in Sweden will be included in the study. A preference-based allocation will be used, participants chose self if they want to participate in in-person yoga at a studio or in yoga online. Regardless of allocation, the yoga sessions will take place in a group setting once a week for a duration of 12 weeks. All participants will also have access to a yoga application on their tablets or cell phones, with a recommendation to engage in self-guided yoga for at least 10 minutes per day.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable cancer
Started Oct 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2023
CompletedFirst Submitted
Initial submission to the registry
January 7, 2024
CompletedFirst Posted
Study publicly available on registry
February 8, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 26, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2025
CompletedMarch 6, 2026
March 1, 2026
1.4 years
January 7, 2024
March 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patients preferences to yoga during oncological treatment
Interviews on choice of yoga setting: physical or digital
Baseline, 3 months and 6 months
Secondary Outcomes (8)
Health-related quality of life
Baseline, 3 months and 6 months
Health
Baseline, 3 months and 6 months
Anxiety and depression
Baseline, 3 months and 6 months
Fatigue
Baseline, 3 months and 6 months
Sleep
Baseline, 3 months and 6 months
- +3 more secondary outcomes
Study Arms (2)
Physical setting
OTHERMedical yoga at a yoga local led by a yoga-instructor for 75 minutes once a week and individual yoga for a minimum of 10 minutes daily using a yoga-application for 12 weeks.
Digital setting
OTHERMedical yoga online using videoconference system led by a yoga-instructor for 75 minutes once a week and individual yoga for a minimum of 10 minutes daily using a yoga-application for 12 weeks.
Interventions
Medical yoga is a therapeutic form of Kundalini yoga led by a certified yoga instructor that uses different standardized yoga programs with a combination of physical postures, breathingexercises, and relaxation/meditation.
Eligibility Criteria
You may qualify if:
- Diagnosed with cancer and scheduled for or initiated oncological treatment at an oncology clinic.
- Received written information about the study.
- Willing to participate in the study and able to follow the protocol.
- Understanding and expressing themselves in Swedish.
- Age ≥ 18 years.
- Provided informed consent.
You may not qualify if:
- Patients with severe cognitive impairments such as dementia and serious psychiatric illness.
- Patients with significant physical disabilities that may hinder yoga.
- Patients with difficulties completing questionnaires.
- Expected survival of less than 3 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Linkoeping Universitylead
- University Hospital, Linkoepingcollaborator
- Ryhov County Hospitalcollaborator
Study Sites (1)
Department of oncology, university hospital
Linköping, 58185, Sweden
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Anna Strömberg, PHD
Department of Medical and Health sciences, Linköping university, Sweden
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- professor
Study Record Dates
First Submitted
January 7, 2024
First Posted
February 8, 2024
Study Start
October 1, 2023
Primary Completion
February 26, 2025
Study Completion
August 31, 2025
Last Updated
March 6, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share